Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, as well as for adjunctive treatment of patients with peroxisomal disorders; and Thiola and Thiola EC, a tiopronin tablet for the treatment of homozygous cystinuria. The company's product candidates also consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis and immunoglobulin A nephropathy; and TVT-058, a novel investigational human enzyme replacement candidate, which is in Phase I/II clinical trials for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and patient advocacy organizations, CDG Care, and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for NGLY1 deficiency and Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Travere Therapeutics Inc..
Travere Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Travere Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Travere Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Travere Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Travere Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Travere Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Travere Therapeutics Inc.- Key Facts
2.2 Travere Therapeutics Inc.- Geographic Locations
2.3 Travere Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Travere Therapeutics Inc.- Business Divisions
2.5 Travere Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Travere Therapeutics Inc. Strategic Analysis Review
3.1 Travere Therapeutics Inc.- Key Strategies
3.2 Travere Therapeutics Inc.- Company Outlook Statement
3.3 Travere Therapeutics Inc.- SWOT Analysis
3.3.1 Travere Therapeutics Inc.- Key Strengths
3.3.2 Travere Therapeutics Inc.- Key Weaknesses
3.3.3 Travere Therapeutics Inc.- Potential Opportunities
3.3.4 Travere Therapeutics Inc.- Potential Threats
3.4 Travere Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Travere Therapeutics Inc.- Business Overview
4.2 Travere Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Travere Therapeutics Inc.- Key Products
5.2 Travere Therapeutics Inc.- Key Service Areas
5.3 Travere Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Travere Therapeutics Inc.- Company History
6.2 Travere Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Travere Therapeutics Inc.- Income Statements
7.2 Travere Therapeutics Inc.- Balance Sheet
7.3 Travere Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Travere Therapeutics Inc.- Direct Competitors
8.2 Travere Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Travere Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Travere Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
